President Joe Biden has been making his case for reelection to voters by telling them he is good for their pocketbooks, including at the pharmacy counter.
CMS to expand access to obesity drugs preventing heart disease: reports
The CMS announcement comes one week after the FDA approved a label expansion for Novo Nordisk’s popular GLP-1 Wegovy to be used as a treatment in heart disease.
Patients see first savings from Biden’s drug price push, as pharma lines up its lawyers
A restructuring of the Medicare drug benefit has wiped out big drug price bills for people who need expensive medicines. But the legal battle over drug negotiations means uncertainty over long-term savings.
After promising to make government healthcare data more accessible, the Biden administration now wants to clamp down
Researchers across the country fear a new proposal by the Centers for Medicare and Medicaid Services will increase fees and decrease access to data used to support major healthcare reforms.
Judge rebuffs PhRMA lawsuit over Medicare power to negotiate drug prices
It’s been a tumultuous 18 months since the passage of Medicare drug price negotiations punctured the lobbying group’s ‘aura of invincibility.’ Is it time for a policy revamp at PhRMA?
The Inflation Reduction Act’s Medicare negotiation process kicks off
The agency has rolled out sweeping changes to target end-of-life care providers that were billing for unneeded services, but some fraud hot spots continue to evade scrutiny.
Older Americans say they feel trapped in Medicare Advantage plans